We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Potential for Anti-Chagas Therapies Using Structure-based Drug Design

News   Sep 27, 2017 | Original story from Tokyo Institute of Technology

 
Potential for Anti-Chagas Therapies Using Structure-based Drug Design

Results of the TcSpdSyn-ligand docking analysis. Docking poses of the top five compounds (green: docking results, pink: dcSAM). This simulation was conducted with the TcSpdSyn X-ray structure (PDB ID code: 3BWC). The docking results show that all compounds bind to the putrescine-binding site and that dcSAM binding in its own site. Credit: Yoshino, R. et al. Sci Rep. (2017). doi:10.1038/s41598-017-06411-9

 
 
 

RELATED ARTICLES

75,000-molecule Screen Reveals Amyloid-reducing Compound

News

Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer’s disease (AD).

READ MORE

Novel Therapeutic Approach to Treat Osteoarthritis

News

Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.

READ MORE

Tiny Atomic Clock Could Enable Communication From Satellite Swarms

News

Scientists at Tokyo Tech, Ricoh co. and The National Institute of Advanced Industrial Science and Technology have developed an ultra-low-power atomic clock (ULPAC) for small satellites to enable future communication systems beyond 5G. The proposed device outperforms the current industry standards in various benchmarks, such as size, stability, and power consumption.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE